Photo of Henrik Green

Henrik Green

Professor

My research aim to improve cancer chemotherapy by predicting pharmacokinetics and side effects. I also work a lot in forensic sciences.

Presentation

Genetics and Toxicology in Cancer Chemotherapy and Forensic Sciences

My research is focused on finding predictive markers and understanding how pharmaceutiacls and drugs yield desired and undesired effects in humans.

Everyone is different and everyone reacts differently to drugs. Our research group studies how genetic variation affects the effect and risk of side effects in cancer treatment. We also work with new psychoactive drugs (internet drugs), their toxicology and pharmacology. Our third track is genetics in a forensic perspective.

Publications

2023

Marie H. Deventer, Mattias Persson, Caitlyn Norman, Huiling Liu, Matthew J. Connolly, Niamh Nic Daeid, Craig McKenzie, Henrik Green, Christophe P. Stove (2023) In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogs Drug Testing and Analysis Continue to DOI
Steven R. Baginski, Tobias Rautio, Lorna A. Nisbet, Karin Lindbom, Xiongyu Wu, Johan Dahlén, Craig Mckenzie, Henrik Green (2023) The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC-QTOF-MS and synthesized reference standards Journal of Analytical Toxicology Continue to DOI
Robert Kronstrand, Markus Roman, Anna Johansson, Xiongyu Wu, Henrik Green, Michael T. Truver (2023) Rilmazafone: A Designer Benzodiazepine Pro-Drug Involved in Fatal Intoxications Journal of Analytical Toxicology Continue to DOI
Hannes Max Schwelm, Mattias Persson, Benedikt Pulver, Max Vincent Huss, Henrik Green, Volker Auwaerter (2023) Pharmacological profile, phase I metabolism, and excretion time profile of the new synthetic cathinone 3,4-Pr-PipVP Drug Testing and Analysis Continue to DOI
Mattias Persson, Svante Vikingsson, Robert Kronstrand, Henrik Green (2023) Characterization of neurotransmitter inhibition for seven cathinones by a proprietary fluorescent dye method Drug Testing and Analysis Continue to DOI

News

Male researcher in lab, blue background light.

SEK 13 million for research into solving murders using AI

Was it murder, poisoning or was the death maybe caused by disease? Researchers have now been granted SEK 13 million from the Swedish Research Council to develop a methodology to solve crimes using detailed analyses and artificial intelligence.

Male researcher in lab, blue background light.

Faster narcotics classification of Internet drugs with new method

NPS, new psychoactive substances, are substances developed to affect the brain in a similar way to illegal drugs. Researchers have set up a rapid method for measuring the effect of new NPS and provide scientific basis for narcotics classification.

women clasping her hands over chest.

Estrogen possible risk factor in disturbed heart rhythm

The sex hormone estrogen has a negative impact on heartbeat regulation, according to an experimental study from LiU. Estrogen impact seems to interact with hereditary changes causing a heart disease disturbing the heart’s rhythm.

Research

Publications

Latest publications

2023

Marie H. Deventer, Mattias Persson, Caitlyn Norman, Huiling Liu, Matthew J. Connolly, Niamh Nic Daeid, Craig McKenzie, Henrik Green, Christophe P. Stove (2023) In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogs Drug Testing and Analysis Continue to DOI
Steven R. Baginski, Tobias Rautio, Lorna A. Nisbet, Karin Lindbom, Xiongyu Wu, Johan Dahlén, Craig Mckenzie, Henrik Green (2023) The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC-QTOF-MS and synthesized reference standards Journal of Analytical Toxicology Continue to DOI
Robert Kronstrand, Markus Roman, Anna Johansson, Xiongyu Wu, Henrik Green, Michael T. Truver (2023) Rilmazafone: A Designer Benzodiazepine Pro-Drug Involved in Fatal Intoxications Journal of Analytical Toxicology Continue to DOI

About me

CV

Currently: 

  • Research strategist / Molecular Biologist in Engineering and Genomics. Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping. 
  • Associate Professor at Division of Drug Research, Department of Medical and Health Sciences, Faculty of Medical Sciences, Linköping University. 

  • 2011--2012. Post-doc at Science for Life Laboratory, Division of Gene technology, Institution for Biotechnology, KTH - Royal Institute of Technology. 
  • 2007 - 2012. Assistant Professor at the Division of Drug Research, Linköping University, Linköping Sweden.
 

Education

  • 2000 - Master of Science in Engineering Biology. Institute of Technology, Linköping University, Linköping, Sweden.    
  • 2007 - PhD in Clinical Pharmacology. Division of Clinical Pharmacology, Department of medicine and Care, Faculty of Health Sciences, Linköping University, Linköping, Sweden. 
  • 2012 - Associate Professor in Pharmacogenetics at Linköping University.

Co-workers

Organisation